Publication Name	World Journal of Gastroenterology
Manuscript ID	18461
Country	Spain

Received	2015-04-21 08:38
Peer-Review Started	2015-04-22 14:40
To Make the First Decision	2015-06-23 15:08
Return for Revision	2015-06-27 16:12
Revised	2015-07-07 14:50
Second Decision	2015-09-12 22:00
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2015-09-14 11:23
Articles in Press	2015-09-14 11:23
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2015-09-22 10:17
Publish the Manuscript Online	2015-10-14 12:06

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Topic Highlights
Article Title	Modulation of host lipid metabolism by hepatitis C virus: Role of new therapies
Manuscript Source	Invited Manuscript
All Author List	José A Del Campo and Manuel Romero-Gómez
Funding Agency and Grant Number
Corresponding Author	José A Del Campo, PhD, Digestive Diseases and CIBERehd, Valme University Hospital, University of Seville, Avda. Bellavista s/n, 41014 Seville, Spain. jantonio.delcampo@ciberehd.org
Key Words	Hepatitis C virus; Lipid metabolism; Direct acting antiviral agents; Genetic interaction; Sofosbuvir
Core Tip	Hepatitis C virus (HCV) is known to be closely related and associated with host lipid metabolism. Recently development of direct acting antiviral agents has shown a very high efficacy (> 90%) in sustained viral response rates even for cirrhotic patients and most of the viral genotypes. HCV RNA clearance induced by Sofosbuvir has been associated with an increased concentration and size of the low-density lipoprotein particles. Host and viral genetic factors play an essential role in chronic infection. Lipid metabolism is hijacked by viral infection and could determine the success of viral replication.
Publish Date	2015-10-14 12:06
Citation	Del Campo JA, Romero-Gómez M. Modulation of host lipid metabolism by hepatitis C virus: Role of new therapies. World J Gastroenterol 2015; 21(38): 10776-10782
URL	http://www.wjgnet.com/1007-9327/full/v21/i38/10776.htm
DOI	http://dx.doi.org/10.3748/wjg.v21.i38.10776

Full Article (PDF)	WJG-21-10776.pdf
Full Article (Word)	WJG-21-10776.doc
Manuscript File	18461-Review.doc
Answering Reviewers	18461-Answering reviewers.pdf
Audio Core Tip	18461-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	18461-Conflict-of-interest statement.pdf
Copyright License Agreement	18461-Copyright assignment.pdf
Peer-review Report	18461-Peer-review(s).pdf
Scientific Misconduct Check	18461-Scientific misconduct check.pdf
Scientific Editor Work List	18461-Scientific editor work list.pdf